SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 198 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,000 | -54.5% | 1,238 | -35.9% | 0.00% | – |
Q1 2022 | $11,000 | -26.7% | 1,931 | -3.8% | 0.00% | – |
Q4 2021 | $15,000 | -6.2% | 2,008 | +13.5% | 0.00% | – |
Q3 2021 | $16,000 | -23.8% | 1,769 | 0.0% | 0.00% | – |
Q2 2021 | $21,000 | -65.6% | 1,769 | -63.9% | 0.00% | -100.0% |
Q1 2021 | $61,000 | +5.2% | 4,900 | +31.5% | 0.00% | 0.0% |
Q4 2020 | $58,000 | +23.4% | 3,727 | -25.1% | 0.00% | 0.0% |
Q3 2020 | $47,000 | +2.2% | 4,979 | +2.6% | 0.00% | 0.0% |
Q2 2020 | $46,000 | – | 4,851 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |